Stanley Black & Decker, Inc. (SWK) Stock Price Today
Aura AI Summary
Key Stats
- $14.01BMarket Cap
- 1,360,192Volume
- IndustrialsSector
- $104.0052W High
- $62.1252W Low
- 62 DaysTypical Hold Time
- $18.17BEnterprise Value
- 3.62%Div Yield
- -Trading Activity
Track Stanley Black & Decker, Inc. (SWK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Stanley Black & Decker, Inc. has traded between a low of $62.12 and a high of $104, highlighting its annual price range. Buy and sell Stanley Black & Decker, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Most Recent News
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.
K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.